MedPage Today (3/4, DePeau-Wilson ) reports, “The proliferation of ketamine clinics in the U.S. has veered far off course from the recommendations of the nation’s premier psychiatric association when it comes to using the anesthetic to treat mood disorders, experts say.” MedPage Today adds, “In 2017, the American Psychiatric Association (APA) issued a consensus statement on the use of ketamine in treating mood disorders, published in JAMA Psychiatry.” However, “the ketamine clinics cropping up across the U.S. don’t appear to follow that guidance, Smita Das, MD, PhD, MPH, of Stanford University and a spokesperson for the APA, told MedPage Today.” Dr. Das said, “[Intravenous] ketamine is being offered in smaller clinics off-label and there isn’t a practice guideline from the American Psychiatric Association that’s recommending ketamine for use in the way that it’s being used.” Dr. Das also “said the surge of ketamine clinics is something of a ‘wild west’ where vulnerable patients are being offered treatment without being informed of the downsides.”
Related Links:
— MedPage Today (requires login and subscription)